Search

Author/Creator Kobos, Rachel

11. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. Issue 10218 (11th January 2020)

Authors:
Mateos, Maria-Victoria; Cavo, Michele; Blade, Joan; Dimopoulos, Meletios A; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Shelekhova, Tatiana; Yo...
Journal:
Lancet
Issue:
Volume 395:Issue 10218(2019)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015)

Authors:
Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 3(2015:Mar.)
Page Start:
284
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015)

Authors:
Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 3(2015:Mar.)
Page Start:
284
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma. (10th March 2020)

Authors:
Abou‐Alfa, Ghassan K.; Mayer, Robert; Venook, Alan P.; O'Neill, Allison F.; Beg, Muhammad S.; LaQuaglia, Michael; Kingham, Peter T.; Kobos, Rachel; Basturk, Olca; Brennan, Cameron; Yopp, Adam; Harding, James J.; Leong, Stephen; Crown, John; Hoti, Emir; Leonard, Gregory; Ly, Michele; Bradley, Mika...
Journal:
Oncologist
Issue:
Volume 25:Number 12(2020)
Page Start:
e1837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Posttransplant Lymphoproliferative Disorder Complicating Hematopoietic Stem Cell Transplantation in a Patient With Dyskeratosis Congenita. (October 2013)

Authors:
Bohn, Olga L.; Whitten, Joseph; Spitzer, Barbara; Kobos, Rachel; Prockop, Susan; Boulad, Farid; Arcila, Maria; Wang, Lu; Teruya-Feldstein, Julie
Journal:
International journal of surgical pathology
Issue:
Volume 21:Number 5(2013)
Page Start:
520
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗